Evaluating the Efficacy and Effectiveness of SCOPE - RCT

NCT03665363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2021-12-13

No results posted yet for this study

Summary

The study will entail an evaluation of the feasibility, acceptability, efficacy and effectiveness of SCOPE coach supported internet-delivered psychoeducative program using a randomized controlled design in a clinical health care context.

An estimated n=175 will be needed to enable block randomisation according a 2:1:1 ratio to: 1) SCOPE internet-based psychoeducation intervention, 2) Self-study controls, who receive eight weekly emails containing informative and relevant websites about Autism Spectrum Disorder (ASD), 3) Wait-list controls.

Conditions

Interventions

OTHER

SCOPE

SCOPE is a internet-delivered, coach-guided, psychoeducational intervention, intended to serve as a first-line intervention for intellectually able adolescents and young adults with ASD. The SCOPE program is based on information comprising neuropsychology, pedagogy, and also interdisciplinary clinical experience regarding ASD. The content is aimed at providing information about typical and specific impairments of ASD, as well as the associated strengths.

OTHER

Self-study

Active control consisting of directed self-studies on internet.

Sponsors & Collaborators

  • Stiftelsen Promobilia

    collaborator UNKNOWN
  • Stiftelsen Sunnerdahls Handikappfond

    collaborator OTHER
  • Stiftelsen Sven Jerrings fond

    collaborator UNKNOWN
  • L.J. Boëthius stiftelse

    collaborator UNKNOWN
  • Stiftelsen Frimurarna Barnhuset

    collaborator UNKNOWN
  • Stockholm County Council ALF/PPG

    collaborator UNKNOWN
  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Tatja Hirvikoski, Associate Professor · Karolinska Insitutet

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2021-08-31
Completion
2021-12-09

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03665363 on ClinicalTrials.gov